Pronađeno: 1-10 / 12 radova

Autori: Ding Wern Yew

>> Filter: Samo Article i Review

Naslov Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry (Article)
Autori Bonini Niccolo  Proietti Marco  Romiti Giulio Francesco  Vitolo Marco  Fawzy Ameenathul Mazaya  Ding Wern Yew  Imberti Jacopo Francesco  Fauchier Laurent  Marin Francisco  Nabauer Michael  Dan Gheorghe Andrei  Potpara Tatjana S  Boriani Giuseppe  Lip Gregory YH  ESCEHRAEORPAF Gen Long Term Registry Investigators 
Info JOURNAL OF THE AMERICAN HEART ASSOCIATION, (2025), vol. 14 br. 1, str. -
Projekat Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific Corporation; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor Pharma
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry (Article)
Autori Ding Wern Yew  Proietti Marco  Romiti Giulio Francesco  Vitolo Marco  Fawzy Ameenathul Mazaya  Boriani Giuseppe  Marin Francisco  Blomstrom-Lundqvist Carina  Potpara Tatjana S  Fauchier Laurent  Lip Gregory YH 
Info EUROPEAN JOURNAL OF INTERNAL MEDICINE, (2023), vol. 107 br. , str. 60-65
Projekat Abbott Vascular Int; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Servier; Edwards; Vifor; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati:
Naslov Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry (Article)
Autori Ding Wern Yew  Blomstrom-Lundqvist Carina  Fauchier Laurent  Marin Francisco  Potpara Tatjana S  Boriani Giuseppe  Lip Gregory YH 
Info EUROPACE, (2023), vol. 25 br. 2, str. 277-282
Projekat Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor; Gedeon Richter Plc.
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry (Article)
Autori Ding Wern Yew  Kotalczyk Agnieszka  Boriani Giuseppe  Marin Francisco  Blomstrom-Lundqvist Carina  Potpara Tatjana S  Fauchier Laurent  Lip Gregory YH 
Info EUROPEAN JOURNAL OF INTERNAL MEDICINE, (2022), vol. 103 br. , str. 41-49
Projekat Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry (Article)
Autori Romiti Giulio Francesco  Proietti Marco  Vitolo Marco  Bonini Niccolo  Fawzy Ameenathul Mazaya  Ding Wern Yew  Fauchier Laurent  Marin Francisco  Nabauer Michael  Dan Gheorghe Andrei  Potpara Tatjana S  Boriani Giuseppe  Lip Gregory YH 
Info BMC MEDICINE, (2022), vol. 20 br. 1, str. -
Projekat Abbott Vascular Int; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC-EHRA EORP AF Long-Term General Registry (Article)
Autori Ding Wern Yew  Boriani Giuseppe  Marin Francisco  Blomstrom-Lundqvist Carina  Potpara Tatjana S  Fauchier Laurent  Lip Gregory YH 
Info EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, (2022), vol. 8 br. 4, str. 372-382
Projekat Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor; Pfizer Alliance
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry (Article)
Autori Ding Wern Yew  Proietti Marco  Boriani Giuseppe  Fauchier Laurent  Blomstrom-Lundqvist Carina  Marin Francisco  Potpara Tatjana S  Lip Gregory YH 
Info EUROPACE, (2022), vol. 24 br. 5, str. 721-728
Projekat Abbott Vascular IntAbbott Laboratories; Amgen Cardiovascular; AstraZenecaAstraZeneca; BayerBayer AG; Boehringer IngelheimBoehringer Ingelheim; Boston ScientificBoston Scientific; Bristol Myers SquibbBristol-Myers Squibb; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and CompanyEli Lilly; Edwards [2016-19]; Gedeon Richter Plc.; Menarini Int. Op.Menarini Group; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIERServier; Vifor; Pfizer Alliance
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry (Article)
Autori Ding Wern Yew  Potpara Tatjana S  Blomstrom-Lundqvist Carina  Boriani Giuseppe  Marin Francisco  Fauchier Laurent  Lip Gregory YH 
Info EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, (2022), vol. 52 br. 6, str. -
Projekat Abbott Laboratories; Amgen Cardiovascular; AstraZeneca; Bayer AG; Boehringer Ingelheim; Boston Scientific; Bristol-Myers Squibb; Pfizer Alliance; Alliance Daiichi
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Digoxin vs. beta-blocker therapy in atrial fibrillation: analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry (Meeting Abstract)
Autori Ding Wern Yew  Proietti Marco  Boriani Giuseppe  Marin Francisco  Blomstrom-Lundqvist Carina  Fauchier Laurent  Potpara Tatjana S  Lip Gregory YH 
Info EUROPEAN HEART JOURNAL, (2021), vol. 42 br. , Suppl. 1, str. 494-494
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Clinical application of the novel 4S-AF scheme for the characterisation of patients with atrial fibrillation: a report from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) registry (Meeting Abstract)
Autori Ding Wern Yew  Proietti Marco  Boriani Giuseppe  Marin Francisco  Blomstrom-Lundqvist Carina  Fauchier Laurent  Potpara Tatjana S  Lip Gregory YH 
Info EUROPEAN HEART JOURNAL, (2021), vol. 42 br. , Suppl. 1, str. 440-440
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
  • 1
  • 2
Ispis zapisa u formatu:TXT | BibTeX